The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.
 
Juliet Gray
Consulting or Advisory Role - EUSA Pharma; Norgine; YmAbs Therapeutics Inc
Research Funding - Celgene/Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Patent #20210346498
Travel, Accommodations, Expenses - EUSA Pharma
 
Lucas Moreno
Honoraria - Bayer (Inst); EUSA Pharma (Inst)
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Norgine (Inst); Novartis (Inst); Shionogi (Inst)
Patents, Royalties, Other Intellectual Property - Member of SIOPEN Executive Committee, SIOPEN receives royalties for the sales of dinutuximab beta (Inst)
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc (Inst)
 
Rebekah Weston
No Relationships to Disclose
 
Giuseppe Barone
Honoraria - EUSA Pharma
Speakers' Bureau - EUSA Pharma
Expert Testimony - EUSA Pharma
Travel, Accommodations, Expenses - EUSA Pharma
 
Alba Rubio
No Relationships to Disclose
 
Guy Makin
No Relationships to Disclose
 
Sucheta Vaidya
No Relationships to Disclose
 
Antony Ng
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Karsten Nysom
Honoraria - Y-mAbs Therapeutics
Consulting or Advisory Role - Bayer; EUSA Pharma; Ymabs Therapeutics Inc
Travel, Accommodations, Expenses - Bayer
 
Genevieve Laureys
No Relationships to Disclose
 
Natasha Van Eijkelenburg
Speakers' Bureau - EUSA Pharma
 
Cormac Owens
No Relationships to Disclose
 
Marion Gambart
No Relationships to Disclose
 
Andrew DJ Pearson
Consulting or Advisory Role - Celgene; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Celgene; Lilly; Merck; Takeda
 
Jennifer Laidler
No Relationships to Disclose
 
Pamela Kearns
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb
Research Funding - Bayer (Inst); Pfizer (Inst)
 
Keith Wheatley
Research Funding - Bayer (Inst); Bio-Cancer Treatment International (Inst); EUSA Pharma (Inst); Roche (Inst)